PG vs PRGO
PG: Global manufacturer and distributor of consumer staples—household, health and personal care products sold under iconic brands to over 180 countries. PRGO: A struggling diversified consumer and prescription healthcare manufacturer navigating portfolio restructuring and strategic divestitures amid margin pressure and competitive headwinds.
Side-by-side fundamentals
| Metric | PG | PRGO | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $149.13 | $10.47 | |
| Market cap as of 2026-07-23 | $348.6B | $1.5B | |
| P/E as of 2026-07-23 | 20.98 | n/a | |
| PEG as of 2026-07-23 | 6.94 | -0.00 | PRGO lower |
| Net margin as of 2026-07-23 | +19.2% | -43.5% | PG higher |
| Gross margin as of 2026-07-23 | +50.9% | +34.2% | PG higher |
| Operating margin as of 2026-07-23 | +23.6% | -36.9% | PG higher |
| ROE as of 2026-07-23 | +31.2% | -50.6% | PG higher |
| ROA as of 2026-07-23 | +13.1% | -19.8% | PG higher |
| Debt / equity as of 2026-07-23 | 0.68 | 1.45 | PG lower |
| Revenue growth (YoY) as of 2026-07-23 | +3.3% | -3.6% | PG higher |
| Revenue CAGR (3y) SEC XBRL | +1.7% | -1.5% | PG higher |
| Dividend yield as of 2026-07-23 | +2.9% | +11.1% | PRGO higher |
| Dividend streak (yrs) SEC XBRL | 3 | 5 | PRGO higher |
| Beta as of 2026-07-23 | 0.38 | 0.53 | |
| 1-year return as of 2026-07-22 close | -5.8% | -62.0% | PG higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.